NAV as of Mar 27, 2024
$76.10
52 WK: 64.60 - 76.10
1 Day NAV Change as of Mar 27, 2024
0.93
(1.24%)
NAV Total Return as of Mar 27, 2024
YTD:
8.78%
Morningstar Rating
5 stars
BRONZE
Overview
About this Fund
1. Access to innovative healthcare equities 2. Investment expertise enhanced by scientific experience 3. Seeks diversified returns with lower volatility
Investment Approach
Invests at least 80% of total assets in securities of companies in health sciences and related industries, and may invest in companies located in non-U.S. countries.